Target intelligence / Profile preview

Intestinal Mixed Micelles (IMM)

Target
IMM
Molecular classification
Other
01

Overview

Intestinal mixed micelles are complex supramolecular aggregates formed in the small intestine during the digestion of dietary fats. They are primarily composed of bile salts, phospholipids, fatty acids, monoglycerides, and cholesterol (StatPearls, NBK525962). Their main biological function is to solubilize hydrophobic lipids and fat-soluble vitamins (A, D, E, and K) in the aqueous environment of the intestinal lumen, facilitating their transport to the brush border membrane of enterocytes for absorption (Vivo Pathophysiology, Bile Acids and Micelles). In clinical pharmacology, these micelles are crucial for the oral bioavailability of lipophilic drugs, which partition into the micellar core to enhance solubility (Journal of Pharmaceutical Sciences, DOI: 10.1002/jps.20382). Drugs like Orlistat interfere with their formation by inhibiting gastric and pancreatic lipases, reducing the availability of fatty acids for micelle assembly (StatPearls, NBK542202). Bile acid sequestrants like Cholestyramine bind to the bile salt components, disrupting the micellar structure and preventing lipid and cholesterol absorption (PubChem, CID 446926). Consequently, they play a significant role in managing conditions like hyperlipidemia and obesity, though their disruption can lead to safety concerns such as steatorrhea and deficiencies in fat-soluble vitamins (NIH, Lipid Digestion and Absorption).

Other names
Mixed micellesBile salt-lipid micellesIntestinal micelles
02

Mechanism of action

Bile acid sequestration and disruption of micellar solubilization

03

Biological functions

Other
04

Disease associations

Cardiovascular diseaseOther
05

Safety considerations

Malabsorption of fat-soluble vitaminsSteatorrheaGastrointestinal distress
06

Interacting drugs

Cholestyramine

8 more in the full profile.

07

Biomarkers

Fecal fatSerum cholesterolSerum bile acids

Beyond the preview

Go deeper on Intestinal Mixed Micelles (IMM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal Mixed Micelles (IMM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call